As of 2024-12-13, the Fair Value of Alnylam Pharmaceuticals Inc (ALNY) is -12.88 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 254.15 USD, the upside of Alnylam Pharmaceuticals Inc is -105.07%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -886.10 | -858.30 | -852.80 | -1,131.20 | -440.24 | -833.73 |
| YoY growth | -16.36% | 3.14% | 0.64% | -32.65% | 61.08% | 3.17% |
| Market Cap (mil) | 32,780.27 |
| P/E | |
| Forward P/E |
| EPS | -2.58 |
| Avg earnings growth rate | 3.17% |
| TTM earnings | -332.26 |